Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Arkolamyl 5mg orodispersible tablets
040201060BDACAS
|
Arkolamyl | Olanzapine | Central Nervous System | No data available |
|
Arpicolin 2.5mg/5ml oral solution
0409020S0BBAAAG
|
Arpicolin | Procyclidine hydrochloride | Central Nervous System | No data available |
|
Arpicolin 5mg/5ml oral solution
0409020S0BBABAH
|
Arpicolin | Procyclidine hydrochloride | Central Nervous System | No data available |
|
Arpoya 15mg tablets
0402010ADBDACAB
|
Arpoya | Aripiprazole | Central Nervous System | No data available |
|
Arpoya 30mg tablets
0402010ADBDADAC
|
Arpoya | Aripiprazole | Central Nervous System | No data available |
|
Asendis 100mg tablets
0403010C0BBACAC
|
Asendis | Amoxapine | Central Nervous System | No data available |
|
Asendis 50mg tablets
0403010C0BBABAB
|
Asendis | Amoxapine | Central Nervous System | No data available |
|
Askit oral powder sachets
0407010W0BBABA0
|
Askit | Aspirin combined preparations | Central Nervous System | No data available |
|
Aspav dispersible tablets
0407010A0BBAAAB
|
Aspav | Aspirin and papaveretum | Central Nervous System | No data available |
|
Aspirin 300mg / Paracetamol 200mg dispersible tab sugar free
0407010S0AAACAC
|
Aspirin/paracetamol | Aspirin and paracetamol | Central Nervous System | No data available |
|
Aspirin 300mg effervescent tablets sugar free
0407010B0AACCCC
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Aspirin 300mg modified-release tablets
0407010B0AACGCG
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Aspirin 300mg orodispersible tablets sugar free
0407010B0AAANAN
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Aspirin 300mg/5ml oral liquid
0407010B0AAABAB
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Aspirin 500mg / Papaveretum 7.71mg dispersible tab SF
0407010A0AAABAB
|
Aspirin/papaveretum | Aspirin and papaveretum | Central Nervous System | No data available |
|
Aspirin 500mg effervescent tablets sugar free
0407010B0AAAGAG
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Aspirin 500mg granules sachets sugar free
0407010B0AACBCB
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Aspirin 600mg / Caffeine 50mg oral powder sachets sugar free
0407010AAAAACAC
|
Aspirin/caffeine | Aspirin and caffeine | Central Nervous System | No data available |
|
Aspirin Extra tablets
0407010W0BKAAA0
|
Lloydspharmacy (Aspirin combined analgesic) | Aspirin combined preparations | Central Nervous System | No data available |
|
Aspirin powder
0407010B0AABRBR
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Aspro Clear 300mg effervescent tablets
0407010B0BGABCC
|
Aspro Clear | Aspirin | Central Nervous System | No data available |
|
Atenza XL 18mg tablets
0404000M0BQADAM
|
Atenza | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Atenza XL 27mg tablets
0404000M0BQACAT
|
Atenza | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Atenza XL 36mg tablets
0404000M0BQABAN
|
Atenza | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Atenza XL 54mg tablets
0404000M0BQAAAR
|
Atenza | Methylphenidate hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.